SA
INSP icon

Strategic Advocates’s Inspire Medical Systems INSP Stock Holding History

Strategic Advocates’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2
Closed -$185 – 433
2025
Q4 		$185 Sell
2
-6
-75% -$574 ﹤0.01% 582
2025
Q3 		$594 Buy
+8
New +$810 ﹤0.01% 518

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Strategic Advocates's INSP Position: Q1 2026 in Review

Strategic Advocates sold out of Inspire Medical Systems (INSP) in Q1 2026, closing a stake of 2 shares — an estimated $185 sold.

Strategic Advocates first reported a position in INSP in Q3 2025 and held it in 2 quarters. The position peaked at $594 in Q3 2025. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

  • Strategic Advocates reported no remaining Inspire Medical Systems position as of Q1 2026 after selling out during the quarter.
  • Strategic Advocates sold 2 Inspire Medical Systems shares in Q1 2026, an estimated $185.
  • Strategic Advocates first reported a position in Inspire Medical Systems in Q3 2025 and held it in 2 quarters.
  • Strategic Advocates's Inspire Medical Systems position peaked at $594 in Q3 2025.
  • 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.